2023-04-012024-03-312024-03-31false09515416ORAL HEALTHCARE LIMITED2024-09-30iso4217:GBPxbrli:pure095154162023-04-01095154162024-03-31095154162023-04-012024-03-31095154162022-04-01095154162023-03-31095154162022-04-012023-03-3109515416bus:SmallEntities2023-04-012024-03-3109515416bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3109515416bus:FullAccounts2023-04-012024-03-3109515416bus:PrivateLimitedCompanyLtd2023-04-012024-03-3109515416core:WithinOneYear2024-03-3109515416core:AfterOneYear2024-03-3109515416core:WithinOneYear2023-03-3109515416core:AfterOneYear2023-03-3109515416core:ShareCapital2024-03-3109515416core:SharePremium2024-03-3109515416core:RevaluationReserve2024-03-3109515416core:OtherReservesSubtotal2024-03-3109515416core:RetainedEarningsAccumulatedLosses2024-03-3109515416core:ShareCapital2023-03-3109515416core:SharePremium2023-03-3109515416core:RevaluationReserve2023-03-3109515416core:OtherReservesSubtotal2023-03-3109515416core:RetainedEarningsAccumulatedLosses2023-03-3109515416core:LandBuildings2024-03-3109515416core:PlantMachinery2024-03-3109515416core:Vehicles2024-03-3109515416core:FurnitureFittings2024-03-3109515416core:OfficeEquipment2024-03-3109515416core:NetGoodwill2024-03-3109515416core:IntangibleAssetsOtherThanGoodwill2024-03-3109515416core:ListedExchangeTraded2024-03-3109515416core:UnlistedNon-exchangeTraded2024-03-3109515416core:LandBuildings2023-03-3109515416core:PlantMachinery2023-03-3109515416core:Vehicles2023-03-3109515416core:FurnitureFittings2023-03-3109515416core:OfficeEquipment2023-03-3109515416core:NetGoodwill2023-03-3109515416core:IntangibleAssetsOtherThanGoodwill2023-03-3109515416core:ListedExchangeTraded2023-03-3109515416core:UnlistedNon-exchangeTraded2023-03-3109515416core:LandBuildings2023-04-012024-03-3109515416core:PlantMachinery2023-04-012024-03-3109515416core:Vehicles2023-04-012024-03-3109515416core:FurnitureFittings2023-04-012024-03-3109515416core:OfficeEquipment2023-04-012024-03-3109515416core:NetGoodwill2023-04-012024-03-3109515416core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3109515416core:ListedExchangeTraded2023-04-012024-03-3109515416core:UnlistedNon-exchangeTraded2023-04-012024-03-3109515416core:MoreThanFiveYears2023-04-012024-03-3109515416core:Non-currentFinancialInstruments2024-03-3109515416core:Non-currentFinancialInstruments2023-03-3109515416dpl:CostSales2023-04-012024-03-3109515416dpl:DistributionCosts2023-04-012024-03-3109515416core:LandBuildings2023-04-012024-03-3109515416core:PlantMachinery2023-04-012024-03-3109515416core:Vehicles2023-04-012024-03-3109515416core:FurnitureFittings2023-04-012024-03-3109515416core:OfficeEquipment2023-04-012024-03-3109515416dpl:AdministrativeExpenses2023-04-012024-03-3109515416core:NetGoodwill2023-04-012024-03-3109515416core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3109515416dpl:GroupUndertakings2023-04-012024-03-3109515416dpl:ParticipatingInterests2023-04-012024-03-3109515416dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3109515416core:ListedExchangeTraded2023-04-012024-03-3109515416dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3109515416core:UnlistedNon-exchangeTraded2023-04-012024-03-3109515416dpl:CostSales2022-04-012023-03-3109515416dpl:DistributionCosts2022-04-012023-03-3109515416core:LandBuildings2022-04-012023-03-3109515416core:PlantMachinery2022-04-012023-03-3109515416core:Vehicles2022-04-012023-03-3109515416core:FurnitureFittings2022-04-012023-03-3109515416core:OfficeEquipment2022-04-012023-03-3109515416dpl:AdministrativeExpenses2022-04-012023-03-3109515416core:NetGoodwill2022-04-012023-03-3109515416core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3109515416dpl:GroupUndertakings2022-04-012023-03-3109515416dpl:ParticipatingInterests2022-04-012023-03-3109515416dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3109515416core:ListedExchangeTraded2022-04-012023-03-3109515416dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3109515416core:UnlistedNon-exchangeTraded2022-04-012023-03-3109515416core:NetGoodwill2024-03-3109515416core:IntangibleAssetsOtherThanGoodwill2024-03-3109515416core:LandBuildings2024-03-3109515416core:PlantMachinery2024-03-3109515416core:Vehicles2024-03-3109515416core:FurnitureFittings2024-03-3109515416core:OfficeEquipment2024-03-3109515416core:AfterOneYear2024-03-3109515416core:WithinOneYear2024-03-3109515416core:ListedExchangeTraded2024-03-3109515416core:UnlistedNon-exchangeTraded2024-03-3109515416core:ShareCapital2024-03-3109515416core:SharePremium2024-03-3109515416core:RevaluationReserve2024-03-3109515416core:OtherReservesSubtotal2024-03-3109515416core:RetainedEarningsAccumulatedLosses2024-03-3109515416core:NetGoodwill2023-03-3109515416core:IntangibleAssetsOtherThanGoodwill2023-03-3109515416core:LandBuildings2023-03-3109515416core:PlantMachinery2023-03-3109515416core:Vehicles2023-03-3109515416core:FurnitureFittings2023-03-3109515416core:OfficeEquipment2023-03-3109515416core:AfterOneYear2023-03-3109515416core:WithinOneYear2023-03-3109515416core:ListedExchangeTraded2023-03-3109515416core:UnlistedNon-exchangeTraded2023-03-3109515416core:ShareCapital2023-03-3109515416core:SharePremium2023-03-3109515416core:RevaluationReserve2023-03-3109515416core:OtherReservesSubtotal2023-03-3109515416core:RetainedEarningsAccumulatedLosses2023-03-3109515416core:NetGoodwill2022-04-0109515416core:IntangibleAssetsOtherThanGoodwill2022-04-0109515416core:LandBuildings2022-04-0109515416core:PlantMachinery2022-04-0109515416core:Vehicles2022-04-0109515416core:FurnitureFittings2022-04-0109515416core:OfficeEquipment2022-04-0109515416core:AfterOneYear2022-04-0109515416core:WithinOneYear2022-04-0109515416core:ListedExchangeTraded2022-04-0109515416core:UnlistedNon-exchangeTraded2022-04-0109515416core:ShareCapital2022-04-0109515416core:SharePremium2022-04-0109515416core:RevaluationReserve2022-04-0109515416core:OtherReservesSubtotal2022-04-0109515416core:RetainedEarningsAccumulatedLosses2022-04-0109515416core:AfterOneYear2023-04-012024-03-3109515416core:WithinOneYear2023-04-012024-03-3109515416core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3109515416core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3109515416core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3109515416core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3109515416core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3109515416core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3109515416core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3109515416core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3109515416core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3109515416core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3109515416core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3109515416core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3109515416core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3109515416core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3109515416core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3109515416core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3109515416core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3109515416core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3109515416core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3109515416core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3109515416core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3109515416core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3109515416core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3109515416core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3109515416core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3109515416core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3109515416core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3109515416bus:Director12023-04-012024-03-3109515416core:FurnitureFittingsToolsEquipment2023-03-3109515416core:FurnitureFittingsToolsEquipment2023-04-012024-03-3109515416core:FurnitureFittingsToolsEquipment2024-03-31

ORAL HEALTHCARE LIMITED

Registered Number
09515416
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

ORAL HEALTHCARE LIMITED
Company Information
for the year from 1 April 2023 to 31 March 2024

Director

PATEL, Sundeep

Registered Address

281 Brownhill Road
Catford
London
SE6 1AE

Registered Number

09515416 (England and Wales)
ORAL HEALTHCARE LIMITED
Balance Sheet as at
31 March 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets319,75039,500
Tangible assets454,62095,545
74,370135,045
Current assets
Debtors5,6289,872280,911
Cash at bank and on hand13,7718,622
303,643289,533
Creditors amounts falling due within one year7(445,123)(455,989)
Net current assets (liabilities)(141,480)(166,456)
Total assets less current liabilities(67,110)(31,411)
Creditors amounts falling due after one year8(38,939)(27,136)
Net assets(106,049)(58,547)
Capital and reserves
Profit and loss account(106,049)(58,547)
Shareholders' funds(106,049)(58,547)
The financial statements were approved and authorised for issue by the Director on 30 September 2024, and are signed on its behalf by:
PATEL, Sundeep
Director
Registered Company No. 09515416
ORAL HEALTHCARE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Intangible assets
Intangible assets have been recognised with a useful economic life of 10 years and amortised over their useful economic life.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows: Fixtures and Fittings - 25% Straight Line Method.
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20242023
Average number of employees during the year64
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 April 23197,500197,500
At 31 March 24197,500197,500
Amortisation and impairment
At 01 April 23158,000158,000
Charge for year19,75019,750
At 31 March 24177,750177,750
Net book value
At 31 March 2419,75019,750
At 31 March 2339,50039,500
4.Tangible fixed assets

Fixtures & fittings

Total

££
Cost or valuation
At 01 April 23171,014171,014
Additions2,4382,438
At 31 March 24173,452173,452
Depreciation and impairment
At 01 April 2375,46975,469
Charge for year43,36343,363
At 31 March 24118,832118,832
Net book value
At 31 March 2454,62054,620
At 31 March 2395,54595,545
5.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables116,727255,526
Amounts owed by group undertakings58,522-
Other debtors111,19425,385
Total286,443280,911
6.Debtors: amounts due after one year

2024

2023

££
Other debtors3,429-
Total3,429-
7.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables369,343200,738
Amounts owed to related parties-255,251
Finance lease and HP contracts27,907-
Other creditors47,873-
Total445,123455,989
8.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts-23,081
Other creditors38,9394,055
Total38,93927,136
9.Obligations under finance leases

2024

2023

££
Finance lease and HP contracts34,884-
10.Related party transactions
Included within the Creditors due within one year is balances owed to Director of £241,271 (2023: £200,738).